Sign in
4

Changes in Ownership

Aptevo Therapeutics Inc. Filed Acc 0001019056-20-000451

Options or other derivatives

  • SVP & Chief Scientific Officer acquired 9,924 shares (grant or award)
  • SVP & Chief Scientific Officer returned 23,201 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Gross Jane A SVP & Chief Scientific Officer 2020-07-27 Returned to the company · Stock Option (right to buy) −2,072 0 D
Gross Jane A SVP & Chief Scientific Officer 2020-07-27 Returned to the company · Stock Option (right to buy) −2,779 0 D
Gross Jane A SVP & Chief Scientific Officer 2020-07-27 Returned to the company · Stock Option (right to buy) −3,908 0 D
Gross Jane A SVP & Chief Scientific Officer 2020-07-27 Returned to the company · Stock Option (right to buy) −2,407 0 D
Gross Jane A SVP & Chief Scientific Officer 2020-07-27 Returned to the company · Stock Option (right to buy) −2,407 0 D
Gross Jane A SVP & Chief Scientific Officer 2020-07-27 Returned to the company · Stock Option (right to buy) −4,814 0 D
Gross Jane A SVP & Chief Scientific Officer 2020-07-27 Returned to the company · Stock Option (right to buy) −4,814 0 D
Gross Jane A SVP & Chief Scientific Officer 2020-07-27 Grant or award · Stock Option (right to buy) +7,784 7,784 D
Gross Jane A SVP & Chief Scientific Officer 2020-07-27 Grant or award · Stock Option (right to buy) +2,140 2,140 D
Loading xslF345X03/gross.xml…